Home2022-03-14T22:17:27+00:00
Loading...
Loading...

Spotlight

Twitter feed

The following #ASCO22 health & safety protocols are in place:
✅ Proof of full vax req'd
⛔ Neg. COVID self-test req'd within 48 hrs prior to arrival
👩‍🔬 Regular onsite testing encouraged (& free)
😷 Masks expected indoors (& available onsite)
More info ➡️ https://t.co/zW1Lf1nnuk

Patients w/ brain tumors face barriers to enrollment in #clinicaltrials. Learn more + approaches to minimizing them in this paper by Drs. Eudocia Lee, Ross Camidge & @GautamMehtaMD. 🧠 https://t.co/oBT6Coqxdo #ASCOEdBook #CNStumors #btsm @CancerResrch

The Victoria’s Secret Global Fund for Women’s Cancers 2022 Career Development Awards, in Partnership with Pelotonia & AACR, are 2-year, $206,000 grants to support breast and gynecologic cancer research by female junior faculty scientists. Apply by June 28:
https://t.co/kMi1QETGF8

May is #OncologyNursingMonth. The AACR recognizes the vital role that oncology nurses play in improving the lives of patients with cancer. Oncology nurses are invited to join the AACR as Affiliate Members. Learn more:
https://t.co/3kDBaJMZtd

A virtual AACR forum will discuss how to accelerate the development of brain tumor therapies at 1 pm EDT on Thurs, May 26. Panelists include @Tsarmstrong01, Chetan Bettegowda, Andrew Kaczynski @KFILE, @michelle_monje, and @roelverhaak. Learn more:
https://t.co/jY8TwckEYm
@CD_AACR

Immune Evasion in Hodgkin and Non-Hodgkin Lymphomas:
Margaret A. Shipp, Scott J. Rodig, and Justin P. Kline will address this topic in a plenary at the Third AACR International Meeting on Advances in Malignant Lymphoma, June 23-26 in Boston:
https://t.co/Tr4jzS2LSZ
#AACRlymph22

Our first CMO @rschilsky will be honored w the Allen S. Lichter Visionary Leader Award at #ASCO22 for decades-long career advancing cancer research & empowering countless clinicians and researchers to improve outcomes for patients. 🎉 #ASCODailyNews

ASCO Honors Dr. Richard Schilsky for Inspiring and Empowering Clinicians to Address Unmet Needs in Cancer Care

Richard L. Schilsky, MD, FACP, FSCT, FASCO, professor emeritus at the University of Chicago, has been honored with the 2022 Allen Lichter Visionary Le...

fal.cn

The AACR Distinguished Lectureship in Breast Cancer Research recognizes outstanding science that has inspired or could inspire new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer. Nominate a colleague by June 30:
https://t.co/oQT7KucTcg

Looking at the role of more-intense therapy in prostate cancer, Dana-Farber's Alicia Morgans, MD, MPH (@CaPsurvivorship ) discusses with @medpagetoday going beyond androgen-deprivation therapy for patients with metastatic #prostatecancer.

Alicia Morgans, MD, on Going Beyond ADT for Metastatic Prostate Cancer

Androgen-deprivation therapy (ADT) is no longer the standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC), outside o...

ms.spr.ly

Recent publications

Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers.
Nature. 2022

Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR
PLoS One. 2022

All publications

Announcements

Research

Target identification and validation image
Target identification and validation
Photo of scientist carefully adding fluid to multiple test tubes
Drug discovery and development
Photo of Belfer Center researcher working at computer
Clinical science and correlatives

Strategic alliances

Graphic showing circular relationship of research, medicine, and industry

Our strategic alliances drive research innovations and lead to improved therapies to benefit cancer patients

Collaborate with us

Our people

Background image is a collage of photos showing Belfer Center members
Our team
Our culture
Background image is a collage of photos showing Belfer Center members

Donor highlight

Robert and Renée Belfer’s transformative cumulative Dana-Farber investment of more than $25 million launched the Robert A. and Renée E. Belfer Center for Applied Cancer Science. Their generosity enabled the Belfer Center to integrate its scientific teams, produce innovative cancer models, partner with industry leaders, and accelerate the development of revolutionary therapies to treat cancer. We are grateful for their vision and incredible support.

Photo of donors, Mr. and Mrs Belfer
Go to Top